Log in or Sign up for Free to view tailored content for your specialty!
Scleroderma News
New ACR SSc-ILD guidelines warn against glucocorticoids as first-line therapy
The American College of Rheumatology “strongly recommends” against the use of glucocorticoids as a first-line therapy for interstitial lung disease in patients with systemic sclerosis-associated ILD, according to newly released guidelines.
Rheumatology, pulmonology must support each other in managing interstitial lung disease
AUSTIN, Texas — Ongoing communication between rheumatology and pulmonology is essential to managing “unpredictable” interstitial lung disease, according to a presenter at the 2023 Rheumatology Nurses Society annual conference.
Log in or Sign up for Free to view tailored content for your specialty!
Concurrent PAH-ILD occurs in 7% of patients with systemic sclerosis
Approximately 7% of patients with systemic sclerosis in an Australian cohort demonstrated concurrent pulmonary arterial hypertension and interstitial lung disease, according to data published in Arthritis Research & Therapy.
Non-pharmacological therapy may benefit hand function in systemic sclerosis
Non-pharmacological strategies such as exercise can improve hand function in patients with systemic sclerosis, according to data published in the International Journal of Rheumatic Diseases.
Disability score predicts fracture risk in systemic sclerosis
Higher disability scores are a potential predictor of fracture risk among patients with systemic sclerosis, according to data published in Arthritis Care & Research.
Botox injections may provide short-term relief to microstomia
OnabotulinumtoxinA offers short-term relief to patients suffering from scleroderma/systemic sclerosis-induced microstomia, according to a study.
‘Disentangling’ disease, treatments and comorbidities can reduce mortality in RMDs
Managing comorbidities is critical to minimizing deaths in patients with rheumatic and musculoskeletal diseases, according to data presented at EULAR 2023 Congress.
Certain elevated biomarkers aid in diagnosis of systemic sclerosis-related ILD
For diagnosing systemic sclerosis-related ILD, Krebs von den Lungen-6, surfactant protein-D and interleukin-8 in blood/bronchoalveolar lavage fluid samples were found to be “reliable biomarkers,” according to results published in Thorax.
Composite serum biomarker may improve identification of interstitial lung disease in SSc
A composite biomarker index could improve the risk stratification and diagnosis of interstitial lung disease in patients with systemic sclerosis, according to data published in Arthritis & Rheumatology.
Recent systemic sclerosis-related pulmonary hypertension patients show better survival
Patients diagnosed with systemic sclerosis-related pulmonary hypertension in the last 10 years had better survival than those diagnosed prior, according to results published in American Journal of Respiratory and Critical Care Medicine.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read